Cargando…
Penfluridol targets acid sphingomyelinase to inhibit TNF signaling and is therapeutic against inflammatory autoimmune diseases
BACKGROUND: Penfluridol, isolated from an FDA-approved small-molecule drug library as an inhibitor of tumor necrosis factor α (TNFα)-stimulated NF-κB activation, is clinically used to treat chronic schizophrenia and related disorders. This study is aimed to investigate the therapeutic effect of penf...
Autores principales: | Chen, Yue-hong, Liu, Rong-han, Cui, Ya-zhou, Hettinghouse, Aubryanna, Fu, Wen-yu, Zhang, Lei, Zhang, Chen, Liu, Chuan-ju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767691/ https://www.ncbi.nlm.nih.gov/pubmed/35045889 http://dx.doi.org/10.1186/s13075-021-02713-6 |
Ejemplares similares
-
Cytosolic Phospholipase A2 Is Required for Fexofenadine’s Therapeutic Effects against Inflammatory Bowel Disease in Mice
por: Zhao, Xiangli, et al.
Publicado: (2021) -
Brain-penetrant heat shock protein amplifier arimoclomol enhances GCase activity in in vitro Gaucher disease models
por: Hettinghouse, Aubryanna, et al.
Publicado: (2018) -
Progranulin acts as a shared chaperone and regulates multiple lysosomal enzymes
por: Jian, Jinlong, et al.
Publicado: (2017) -
Antimicrobial, Antibiofilm, and Anti-persister Activities of Penfluridol Against Staphylococcus aureus
por: Liu, Yaqian, et al.
Publicado: (2021) -
Drug repurposing: Antimicrobial and antibiofilm effects of penfluridol against Enterococcus faecalis
por: Zeng, Xianghai, et al.
Publicado: (2020)